NCT02705235

Brief Summary

Stress is an important determinant of pregnancy health behaviors, maternal physiology and maternal-infant health outcomes. The purpose of this study is to explain the relationship between dimensions of lifetime stress and the stress hormone cortisol in pregnant women. Additionally, the study will examine how coping styles help pregnant women to better manage stress and improve their health behaviors to achieve the goal of having a healthy baby.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 5, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 10, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

November 28, 2023

Status Verified

November 1, 2023

Enrollment Period

7 months

First QC Date

March 5, 2016

Last Update Submit

November 21, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Cortisol Awakening Response

    Participants will collect saliva samples at home by chewing a cotton swab for 1 to 2 minutes. Samples will be collected five times a day for three days. The swab is then placed in a labeled plastic container and stored the container in a home refrigerator. Once returned to the lab, the samples are processed for cortisol awakening response.

    26 weeks gestation

  • Diurnal Slope

    Participants will collect saliva samples at home by chewing a cotton swab for 1 to 2 minutes. Samples will be collected five times a day for three days. The swab is then placed in a labeled plastic container and stored the container in a home refrigerator. Once returned to the lab, the samples are processed for diurnal slope.

    26 weeks gestation

  • Area Under the Curve (AUC)-Increase

    Participants will collect saliva samples at home by chewing a cotton swab for 1 to 2 minutes. Samples will be collected five times a day for three days. The swab is then placed in a labeled plastic container and stored the container in a home refrigerator. Once returned to the lab, the samples are processed for index of the sensitivity of the cortisol response to a stressor (AUC-Increase).

    26 weeks gestation

  • Area Under the Curve (AUC)-Ground

    Participants will collect saliva samples at home by chewing a cotton swab for 1 to 2 minutes. Samples will be collectd five times a day for three days. The swab is then placed in a labeled plastic container and stored the container in a home refrigerator. Once returned to the lab, the samples are processed for total systemic "output" throughout all salivary cortisol measures (AUC-Ground).

    26 weeks gestation

Eligibility Criteria

Age19 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women aged 19 to 45 years old.

You may qualify if:

  • Single intrauterine pregnancy at least 20 weeks gestation
  • Aged 19 to 45
  • Ability to read and speak English
  • Able to be reached by telephone or text most days of the week

You may not qualify if:

  • Receiving or referred for care in the high-risk prenatal clinic
  • Have any of the following pregnancy complications or medical issues existing prior to recruitment:
  • Cervical or uterine abnormalities, renal, hepatic or cardiac disorders, insulin-dependent diabetes, preeclampsia, regular oral steroid use in the month prior to data collection, congenital fetal abnormalities, active placenta previa, blood group isoimmunization, or other disorders/medication use that could affect cortisol levels
  • Regular night-shift work or reversed sleep schedule

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nebraska Medicine

Omaha, Nebraska, 68198, United States

Location

MeSH Terms

Conditions

Health Behavior

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Crystal Epstein, PhD

    University of Nebraska

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 5, 2016

First Posted

March 10, 2016

Study Start

January 1, 2016

Primary Completion

August 1, 2016

Study Completion

August 1, 2016

Last Updated

November 28, 2023

Record last verified: 2023-11

Locations